drugset / Trial / NCT03101501

A Prospective Study To Evaluate The Raindrop Near Vision Inlay In Presybopic or Pseudophakic Patients Treated With Mitomycin C Following Femtosecond Flap Creation.

NCT03101501

Phase 4 Terminated 9 enrolled Key-Whitman Eye Center
NaSingle-groupOpen-labelPrevention

Summary

The clinical objective of this study is to evaluate the Raindrop® Near Vision Inlay for the improvement of near vision in presbyopic or pseudophakic patients treated with low dose Mitomycin C immediately following femtosecond flap creation.

Timeline

Start
2017-02-14
Primary completion
2018-02-01
Completion
2018-02-01

Drugs

EvaluationDrugModalityDoseRoute
Background Mitomycin C Other / unclassified 0.02 %

Indications